5EB

ethyl (2Z,4S)-4-{[N-(3-cyclopropylpropanoyl)-L-phenylalanyl]amino}-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate

Created:	2015-09-16
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 5EB is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	69
Chiral Atom Count	3
Bond Count	71
Aromatic Bond Count	6

2D diagram of 5EB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	ethyl (2Z,4S)-4-{[N-(3-cyclopropylpropanoyl)-L-phenylalanyl]amino}-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate
Systematic Name (OpenEye OEToolkits)	ethyl (4S)-4-[[(2S)-2-(3-cyclopropylpropanoylamino)-3-phenyl-propanoyl]amino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pent-2-enoate
Formula	C₂₆ H₃₅ N₃ O₅
Molecular Weight	469.573
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C(Cc1ccccc1)(C(=O)NC(\C=C/C(=O)OCC)CC2C(NCC2)=O)NC(=O)CCC3CC3
SMILES	CACTVS	3.385	CCOC(=O)C=C[CH](C[CH]1CCNC1=O)NC(=O)[CH](Cc2ccccc2)NC(=O)CCC3CC3
SMILES	OpenEye OEToolkits	1.9.2	CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(Cc2ccccc2)NC(=O)CCC3CC3
Canonical SMILES	CACTVS	3.385	CCOC(=O)\C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCC3CC3
Canonical SMILES	OpenEye OEToolkits	1.9.2	CCOC(=O)C=C[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCC3CC3
InChI	InChI	1.03	InChI=1S/C26H35N3O5/c1-2-34-24(31)13-11-21(17-20-14-15-27-25(20)32)28-26(33)22(16-19-6-4-3-5-7-19)29-23(30)12-10-18-8-9-18/h3-7,11,13,18,20-22H,2,8-10,12,14-17H2,1H3,(H,27,32)(H,28,33)(H,29,30)/t20-,21+,22-/m0/s1
InChIKey	InChI	1.03	QRJJXRNUFIJDHO-BDTNDASRSA-N

Related Resource References

Resource Name	Reference
PubChem	137348346

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.